http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2180822-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72e2a023c558b51d973e979033b70490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716283b4d47c7564eba0b73a2e3c1704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 1999-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6200a9efb70c4ad85f11b03f02b0424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18183e9d8c51cdcfd13c9e6c16395a65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c444521073e86b543f0ef60f5f9aa14f
publicationDate 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2180822-C2
titleOfInvention Method for treating anterior eye surface diseases and injuries
abstract FIELD: medicine. SUBSTANCE: method involves administering aqueous solution of pentaaqua-mono- and tetra-aqua-dinitrozyl complexes of bivalent iron in 9 mmole/l concentration at a dose of 2 drops into conjunctival cavity 3 times a day. EFFECT: enhanced effectiveness of treatment; accelerated reparative processes; reduced inflammation manifestations. 1 dwg, 3 tbl
priorityDate 1999-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11963622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581073

Total number of triples: 22.